Literature DB >> 14693778

The relation of Graves' ophthalmopathy to circulating thyroid hormone status.

J M Kim1, L LaBree, L Levin, S E Feldon.   

Abstract

AIM: The risk factors and epidemiological data for Graves' ophthalmopathy with and without abnormal circulating thyroid levels were examined to determine the relation of thyroid dysfunction to ophthalmopathy.
METHODS: The authors retrospectively evaluated 482 patients seen with Graves' ophthalmopathy. Of these, 413 were classified as having abnormal levels of circulating thyroid hormone (ALTH) and 69 as having normal levels of circulating thyroid hormone (NLTH).
RESULTS: Patients in the NLTH group, compared to the ALTH group, were older on average (56 (SD 13.5) v 52 (15.4)) and had a higher age adjusted body mass index (26.1 (0.8) v 23.4 (0.3)). In addition, a higher percentage of NLTH patients had hypercholesterolaemia. Those in the ALTH group were more likely to be female (76% v 51%), to have a family history of thyroid problems, and to have had eye surgery.
CONCLUSION: NLTH and ALTH appear to differ from each other in terms of risk factors and epidemiological characteristics. Additionally, thyroid dysfunction seems to be associated with a more severe ophthalmopathy compared to the euthyroid state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693778      PMCID: PMC1771965          DOI: 10.1136/bjo.88.1.72

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

Review 1.  The pathogenesis of Graves' disease: an overview.

Authors:  R Volpé
Journal:  Clin Endocrinol Metab       Date:  1978-03

2.  The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E.

Authors:  T O'Brien; K Katz; D Hodge; T T Nguyen; B A Kottke; I D Hay
Journal:  Clin Endocrinol (Oxf)       Date:  1997-01       Impact factor: 3.478

3.  Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.

Authors:  D Inoue; K Sato; M Maeda; H Inoko; K Tsuji; T Mori; H Imura
Journal:  Clin Endocrinol (Oxf)       Date:  1991-01       Impact factor: 3.478

4.  Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.

Authors:  M F Prummel; W M Wiersinga; M P Mourits; L Koornneef; A Berghout; R van der Gaag
Journal:  Arch Intern Med       Date:  1990-05

5.  Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?

Authors:  L Tallstedt; G Lundell; H Blomgren; J Bring
Journal:  Eur J Endocrinol       Date:  1994-05       Impact factor: 6.664

6.  Identification of subgroups of euthyroid graves's ophthalmopathy.

Authors:  D H Solomon; I J Chopra; U Chopra; F J Smith
Journal:  N Engl J Med       Date:  1977-01-27       Impact factor: 91.245

7.  Antibodies to orbital tissues in thyroid-associated ophthalmopathy.

Authors:  P Perros; P Kendall-Taylor
Journal:  Acta Endocrinol (Copenh)       Date:  1992-02

8.  Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities.

Authors:  M Salvi; Z G Zhang; D Haegert; M Woo; A Liberman; L Cadarso; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

9.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.

Authors:  L Tallstedt; G Lundell; O Tørring; G Wallin; J G Ljunggren; H Blomgren; A Taube
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

10.  Circulating lipids and minor abnormalities of thyroid function.

Authors:  J V Parle; J A Franklyn; K W Cross; S R Jones; M C Sheppard
Journal:  Clin Endocrinol (Oxf)       Date:  1992-11       Impact factor: 3.478

View more
  9 in total

Review 1.  Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.

Authors:  Ozan Cem Guler; Cem Onal; Gungor Arslan
Journal:  Wien Klin Wochenschr       Date:  2015-10-14       Impact factor: 1.704

2.  Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.

Authors:  Ji Hwan Lee; Sang Yeul Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2010-10-05

3.  Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.

Authors:  Ajay E Kuriyan; Richard P Phipps; Charles W O'Loughlin; Steven E Feldon
Journal:  Thyroid       Date:  2008-08       Impact factor: 6.568

Review 4.  Immune mechanisms in thyroid eye disease.

Authors:  Geniece M Lehmann; Steven E Feldon; Terry J Smith; Richard P Phipps
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

5.  Effect of near-total thyroidectomy on thyroid orbitopathy due to toxic goiter.

Authors:  Yasser A Elsayed; Atif M Abdul-Latif; Mukhtar F Abu-Alhuda; Hosam A-F Halim
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

6.  A case of protruding eyeballs and diminishing vision.

Authors:  Rakesh Biswas; Saroj Gupta; Sumit Dahiya; Shashi Kiran; B V Girish; A S Kasthuri
Journal:  Clin Med Case Rep       Date:  2010-01-20

7.  The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy.

Authors:  Karolien Termote; Brigitte Decallonne; Ilse Mombaerts
Journal:  J Ophthalmol       Date:  2014-06-22       Impact factor: 1.909

Review 8.  Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.

Authors:  Caroline Y Yu; Rebecca L Ford; Sara T Wester; Erin M Shriver
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

9.  Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation.

Authors:  G M Lehmann; T M Garcia-Bates; T J Smith; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.